Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
®
Official reprint from UpToDate
www.uptodate.com ©2019 UpToDate, Inc. and/or its affiliates. All Rights Reserved.
All topics are updated as new evidence becomes available and our peer review process is complete.
Literature review current through: Mar 2019. | This topic last updated: May 10, 2018.
INTRODUCTION
The pericardium is a fibroelastic sac made up of visceral and parietal layers separated by a (potential)
space, the pericardial cavity. In healthy individuals, the pericardial cavity contains 15 to 50 mL of an
ultrafiltrate of plasma. Pericardial diseases are relatively common in clinical practice and may have
different presentations either as isolated disease or as a manifestation of a systemic disorder.
Although the etiology is varied and complex, the pericardium has a relatively non-specific response to
these different causes with inflammation of the pericardial layers and possible increased production
of pericardial fluid. Chronic inflammation with fibrosis and calcification can lead to a rigid, usually
thickened and calcified pericardium, with possible progression to pericardial constriction. In some
cases, the clinical presentation of acute pericardial inflammation predominates, and the presence of
excess pericardial fluid is clinically unimportant. In other cases, the effusion and its clinical
consequences (ie, cardiac tamponade and constrictive pericarditis) are of primary importance.
This topic will provide a brief overview of the major causes of pericardial disease. Details of the specific
pericardial disorders are discussed separately. (See "Acute pericarditis: Clinical presentation
and diagnostic evaluation" and "Diagnosis and treatment of pericardial effusion" and
"Constrictive pericarditis".)
CLASSIFICATION
The etiology of pericardial diseases is best considered by using a modification of the time-honored
pathologic classification of disease into inflammatory, neoplastic, vascular, congenital, and
idiopathic causes (table 1) [3-5]. The major causes include:
● Infectious
• Viral, including HIV
• Bacterial, fungal (purulent)
• Others (Rickettsia, Chlamydia, Borrelia, Mycoplasma, Treponema, Ureaplasma,
Nocardia, Tropheryma)
● Radiation
● Post cardiac injury syndrome
• Post-myocardial infarction
• Post-pericardiotomy
• Post-traumatic (including iatrogenic)
● Drugs and toxins
● Metabolic (uremia, dialysis-associated, myxedema, ovarian hyperstimulation syndrome)
● Malignancy (especially lung and breast cancer, Hodgkin lymphoma, and mesothelioma)
● Collagen vascular disease
● Idiopathic or immune-mediated [6,7]
Pericardial disease may also be a component of other, systemic disorders, including inflammatory
bowel disease and familial Mediterranean fever. Aortic dissection or left ventricular free wall rupture
should also be considered in patients with unstable hemodynamics and pericardial effusion.
Most of the etiologies of pericardial disease listed above can cause both "dry" pericarditis (that is,
pericardial inflammation with minimal or no effusion) and pericardial effusive disease with or
without inflammation.
The frequency of the specific causes of pericardial disease varies in published reports, depending
in part upon geography, the patient population, and how the diagnosis was established.
Acute pericarditis — Acute pericarditis can present in a variety of ways, depending on the underlying
etiology (table 2). Patients with an infectious etiology may present with signs and symptoms of
systemic infection such as fever and leukocytosis. Viral etiologies in particular may be preceded by
"flu-like" respiratory or gastrointestinal symptoms. Patients with a known autoimmune disorder or
malignancy may present with signs or symptoms specific to their underlying disorder.
● Chest pain – Typically sharp and pleuritic, improved by sitting up and leaning forward
● Pericardial friction rub – A superficial scratchy or squeaking sound best heard with the
diaphragm of the stethoscope over the left sternal border
● Electrocardiogram (ECG) changes – New widespread ST elevation or PR depression
● Pericardial effusion
At least two of these features should be present to make the diagnosis. (See "Acute pericarditis:
Clinical presentation and diagnostic evaluation", section on 'Clinical features'.)
Several case series have reported estimates of the frequency of specific causes of pericardial
effusion (table 3) [9-13]. Not surprisingly, the distribution of causes varies with demographics and
diagnostic strategies. For example, polymerase chain reaction (PCR) is more sensitive for the
detection of infection than cultures; therefore, a study employing PCR will likely have an
increased incidence of infectious etiologies. The increased incidence of iatrogenic effusions in the
more contemporary series (table 3) reflects the growing number of invasive cardiovascular
procedures being performed.
A series from the United States evaluated 96 cases of hemorrhagic pericardial effusion complicated by
tamponade and requiring pericardiocentesis. The following causes were identified [14]:
● Malignancy – 26 percent
● Percutaneous interventional procedures – 18 percent
● Post-pericardiotomy syndrome – 13 percent
● Complications of myocardial infarction (free wall rupture, thrombolysis) – 11 percent
● Idiopathic – 10 percent
● Other causes (including uremia, aortic dissection, trauma, etc) – 22 percent
Because efforts to diagnose viral infections were not undertaken, the frequency of hemorrhagic
effusions in viral pericarditis was not addressed. In addition, tuberculosis is a frequent cause of
hemorrhagic effusion in areas in which this infection is common. (See "Tuberculous pericarditis".)
Constrictive pericarditis — Patients with constrictive pericarditis typically present with symptoms
related to fluid overload (ranging from peripheral edema to anasarca), symptoms related to
diminished cardiac output in response to exertion (eg, fatigability and dyspnea on exertion) or at rest,
or both. Patients typically present months to years after an initial insult involving the pericardium,
although the majority of patients with prior involvement of the pericardium do not develop constrictive
pericarditis. While the diagnosis of constrictive pericarditis is often made by echocardiography,
patients commonly undergo cardiac catheterization, during which invasive hemodynamic evaluation
is important to confirm the diagnosis. (See "Constrictive pericarditis".)
https://www.uptodate.com/contents/etiology-of-pericardial-disease/print?search=efusi pericard&source=search_result&selectedTitle=18~150&usage_… 4/20
4/10/2019 Etiology of pericardial disease - UpToDate
The yield of a full diagnostic evaluation is much lower in patients presenting primarily with acute
pericarditis than in those whose presentation includes a significant pericardial effusion. In two
series with a total of 331 patients with acute pericarditis, a specific diagnosis was established in
only 16 percent [17,18]. The most common were neoplasia (6 percent), tuberculosis (4 percent),
nontuberculous infection (2 percent), and collagen vascular disease (2 percent).
In patients with acute pericarditis in whom no cause is identified (idiopathic pericarditis), the etiology
is frequently presumed to be viral or immune-mediated [6,7], but evidence for this is usually not
sought because of the expense involved, the inaccessibility of pericardial tissue/fluid, and the time
delay and inaccuracy of viral titers. It is possible that many cases in which an identifiable cause
exists are labeled "idiopathic pericarditis" as a result of an insufficiently rigorous diagnostic
evaluation. However, a complex and exhaustive testing strategy is typically not justified in such
patients given the limited implications for clinical management. One clinically important exception to
this approach is the absence of a prompt and adequate response to standard treatment, in which
case more aggressive efforts at establishing a diagnosis are warranted.
Epicardial/pericardial biopsy using pericardioscopy has improved the diagnostic yield, but it is not
widely available. It may be useful for relapsing cardiac tamponade, suspected bacterial or
neoplastic pericarditis, worsening pericarditis without a definitive diagnosis despite medical
treatment, and symptomatic moderate to large pericardial effusions [2,19].
INFECTION
Virtually any infectious organism can infect the pericardium (table 1). While most infectious causes
of pericardial disease result in a typical acute presentation (ie, acute pericarditis or pericardial
effusion), some organisms, especially bacteria and fungi, can cause a purulent inflammatory
exudate. (See "Purulent pericarditis".)
The frequency of specific pathogens in infectious pericardial disease has been changing in
recent decades and continues to vary with geography. Tuberculous pericarditis has become
much less common in developed countries, while HIV infection remains an important cause of
pericardial disease in the developing world.
The clinical manifestations are often confined to the pericardium, as in viral pericarditis, but
extrapericardial infection may be a prominent component of the clinical picture, as in pneumonia
or empyema with associated pericardial involvement. In some cases, particularly with tuberculous
or fungal infection, an infectious pericarditis can result in chronic constrictive pericarditis. (See
"Tuberculous pericarditis" and "Constrictive pericarditis".)
Viral — Though the most common viral infections causing pericarditis are reported to be
coxsackievirus (types A and B) and echovirus, most of these data come from children diagnosed
by serologic testing in the 1960s. More recent data suggest that adult patients are more commonly
infected with cytomegalovirus and herpes viruses as well as HIV (table 1) [10,20]. There are many
viruses that have been associated with transient pericardial inflammation, which resolves without
sequelae. Pericarditis, usually with myocarditis, has also been described as an infrequent
complication of smallpox vaccination. (See "Myopericarditis", section on 'Vaccinia-associated
myopericarditis'.)
Viral infection is less common among patients who present with pericardial effusion without
pericarditis, especially if the effusion is large (table 3). An exception to this may be patients with
HIV, in whom pericardial effusion seems more prevalent. However, this high frequency may well be
decreasing as more and more patients infected with HIV are receiving aggressive therapy. (See
"Cardiac and vascular disease in HIV-infected patients", section on 'Pericardial disease'.)
Bacterial — While any bacterial infection may involve the pericardium (table 1), the most
notable organisms include Staphylococcus, Pneumococcus, Streptococcus (rheumatic
pancarditis), Haemophilus, and M. tuberculosis. Less common bacteria have the potential to
invade the pericardium when the bacterial flora have been altered by prolonged antibiotic use
and when the immune system is seriously compromised. (See "Purulent pericarditis" and
"Tuberculous pericarditis".)
Other infectious causes — A variety of fungi and parasites are also known to cause
pericardial disease (table 1), particularly in endemic areas or in immunocompromised patients.
https://www.uptodate.com/contents/etiology-of-pericardial-disease/print?search=efusi pericard&source=search_result&selectedTitle=18~150&usage_… 6/20
4/10/2019 Etiology of pericardial disease - UpToDate
MALIGNANCY
In two large series, malignancy was responsible for approximately 6 percent of cases of acute
pericardial disease (acute pericarditis or tamponade without apparent cause) [17,18]. In addition,
malignancy accounts for approximately 15 to 20 percent of moderate to large pericardial
effusions (table 3) [9,10]. (See "Pericardial disease associated with malignancy".)
Virtually any malignant tumor can metastasize to the pericardium, with the most common being
lung and breast cancer and Hodgkin lymphoma. Primary tumors of the pericardium are rare and
include several different types. In many cases, it is not easy to decide whether pericardial disease
is a manifestation of the malignancy itself or of treatment with radiation or chemotherapy. (See
"Pericardial disease associated with malignancy", section on 'Pericardial effusion with or without
cardiac tamponade'.)
Pericarditis with or without a pericardial effusion resulting from injury of the pericardium constitutes
the post-cardiac injury syndrome. The principal conditions considered under this rubric are
postmyocardial infarction syndrome, post-pericardiotomy syndrome, and posttraumatic
pericarditis. (See "Post-cardiac injury syndromes".)
Left ventricular free wall rupture can also occur after a myocardial infarction. Affected patients
have a large hemorrhagic pericardial effusion and tamponade, and the diagnosis is suggested
by the development of sudden, profound heart failure and shock. This syndrome is discussed
separately. (See "Mechanical complications of acute myocardial infarction", section on 'Rupture
of the left ventricular free wall'.)
Pericardial effusion occurring within hours after cardiac surgery is more often associated with
pericardial bleeding, is presumably not due to the post-cardiac injury syndrome, and is frequently
associated with cardiac tamponade [25]. Post-cardiac surgery tamponade is often atypical and may
be associated with left rather than right ventricular compression on echocardiography.
Pericardial effusion also occurs in 9 to 21 percent of patients after cardiac transplantation [26,27].
RADIATION
Prior mediastinal radiation is an important cause of pericardial disease. Most cases are secondary to
radiation therapy for Hodgkin lymphoma or breast or lung cancer. Less commonly, radiation
exposure occurs with thoracic radiation for other conditions (eg, esophageal cancer). However,
improved shielding and dose calculation have reduced the incidence of this complication. (See
"Cardiotoxicity of radiation therapy for breast cancer and other malignancies".)
Soon after radiation, the patient may develop acute pericarditis with or without effusion [28]. Late
onset of pericardial disease is common and is not necessarily preceded by acute pericarditis
[29]. The late pericardial disease may consist of effusive constrictive pericarditis or classic
constrictive pericarditis. (See "Constrictive pericarditis".)
The list of drugs and toxins that can cause pericardial disease is long (table 4).
● Minoxidil (among other drugs) may produce an idiosyncratic reaction with pericardial effusion.
● Doxorubicin and daunorubicin are more often associated with a cardiomyopathy, but may
cause pericardial disease, as may other chemotherapy agents. (See "Cardiotoxicity of non-
anthracycline cancer chemotherapy agents".)
Asbestos exposure, resulting in asbestosis, can also induce pericardial lesions, commonly in
conjunction with pleural and parenchymal lung disease. (See "Asbestos-related
pleuropulmonary disease".)
SYSTEMIC DISORDERS
● Collagen vascular disease – A number of rheumatic diseases can involve the pericardium.
Symptomatic pericarditis can occur with all of these disorders, while pericardial effusion, when
present, is usually clinically silent. This is most likely to occur in systemic lupus erythematosus
(SLE) and rheumatoid arthritis. In SLE, for example, the pericardium is involved in almost one-
half of patients [30]. (See "Non-coronary cardiac manifestations of systemic lupus
erythematosus in adults".)
● Uremia and dialysis – Important causes of metabolic pericardial disease are uremia (which
causes pericarditis in 6 to 10 percent of patients with advanced renal failure who are not being
dialyzed) and dialysis-related pericardial effusion (occurring in approximately 13 percent of
patients). Both inadequate dialysis (ie, uremic pericarditis) and fluid overload may contribute
to the latter disorder [31,32]. An important clinical feature of uremic pericarditis is that the
electrocardiogram does not usually show typical diffuse ST elevation, presumably because
epicardial injury is uncommon [32]. The presence of ST-T abnormalities suggests some other
cause for the pericarditis. (See "Pericarditis in renal failure".)
● GI disease – The pericardium can also be involved in gastrointestinal diseases. These include
inflammatory bowel disease (ulcerative colitis and Crohn's disease) and Whipple's disease.
(See "Whipple's disease".)
IDIOPATHIC
● In patients with acute pericarditis, a cause is identified in only about 16 percent, based on two
large series [17,18]. The etiology in the remaining patients is frequently presumed to be viral,
but evidence for this is often not sought because of the expense involved, the inaccessibility of
pericardial tissue/fluid, and the time delay and inaccuracy of viral titers. (See "Acute pericarditis:
Clinical presentation and diagnostic evaluation".)
● By comparison, a specific etiology can be established in many patients with moderate to large
pericardial effusions (table 3). In two series, a diagnosis of idiopathic disease was made in only
7 to 29 percent of patients [9,10]. (See "Diagnosis and treatment of pericardial effusion".)
UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics."
th th
The Basics patient education pieces are written in plain language, at the 5 to 6 grade reading
level, and they answer the four or five key questions a patient might have about a given condition.
These articles are best for patients who want a general overview and who prefer short, easy-to-read
materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more
th th
detailed. These articles are written at the 10 to 12 grade reading level and are best for patients
who want in-depth information and are comfortable with some medical jargon.
Here are the patient education articles that are relevant to this topic. We encourage you to print or
e-mail these topics to your patients. (You can also locate patient education articles on a variety of
subjects by searching on "patient info" and the keyword(s) of interest.)
● Beyond the Basics topic (see "Patient education: Pericarditis (Beyond the Basics)")
SUMMARY
● In patients with acute pericarditis in whom no cause is identified (idiopathic pericarditis), the
etiology is frequently presumed to be viral, and extensive evaluation for a specific diagnosis is
usually not necessary. However, if a prompt and adequate response to standard treatment is
not seen, more aggressive efforts at establishing a specific etiology are warranted. (See 'Acute
pericarditis' above and "Acute pericarditis: Clinical presentation and diagnostic evaluation".)
● Though the most common viral infections causing pericarditis are reported to be coxsackievirus
(types A and B) and echovirus, most of these data come from children diagnosed by serologic
testing in the 1960s. More recent data suggest that adult patients are more commonly infected with
cytomegalovirus and herpes viruses as well as HIV (table 1). (See 'Viral' above.)
● Prior mediastinal radiation is an important cause of pericardial disease, with most cases following
radiation therapy for Hodgkin lymphoma, breast cancer, or lung cancer. Soon after radiation, the
patient may develop acute pericarditis with or without effusion. Late onset of pericardial disease
is common and may consist of effusive constrictive pericarditis, classic constrictive pericarditis,
or pericardial effusion with or without tamponade. (See 'Radiation' above and "Cardiotoxicity of
radiation therapy for breast cancer and other malignancies".)
● Both pericarditis and pericardial effusion can occur following an acute myocardial infarction (MI).
An effusion that occurs early after MI is related to the acute inflammation associated with the
infarct, while immunologic mechanisms are responsible for effusions that occur several weeks
to months after the infarct. (See 'Post-cardiac injury syndromes' above and "Pericardial
complications of myocardial infarction", section on 'Post-MI pericardial effusion'.)
REFERENCES
1. Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol 2012; 27:308.
2. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management
of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial
Diseases of the European Society of Cardiology (ESC)Endorsed by: The European
Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015; 36:2921.
3. Spodick DH. The Pericardium: A Comprehensive Textbook, Marcel Dekker, New York 1997.
p.2 60.
4. Spodick DH. Pericardial disease. In: Heart Disease: A Textbook of Cardiovascular Medicine,
Br aunwald E, Zipes D, Libby P (Eds), Saunders, New York 2001. p.183.
5. Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet 2004; 363:717.
6. Caforio AL, Brucato A, Doria A, et al. Anti-heart and anti-intercalated disk autoantibodies:
evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart 2010; 96:779.
10. Corey GR, Campbell PT, Van Trigt P, et al. Etiology of large pericardial effusions. Am J
Med 1993; 95:209.
11. Levy PY, Corey R, Berger P, et al. Etiologic diagnosis of 204 pericardial effusions.
Medicine (Baltimore) 2003; 82:385.
14. Atar S, Chiu J, Forrester JS, Siegel RJ. Bloody pericardial effusion in patients with
cardiac tamponade: is the cause cancerous, tuberculous, or iatrogenic in the 1990s?
Chest 1999; 116:1564.
16. Kim KH, Miranda WR, Sinak LJ, et al. Effusive-Constrictive Pericarditis After Pericardiocentesis:
Incidence, Associated Findings, and Natural History. JACC Cardiovasc Imaging 2018; 11:534.
18. Zayas R, Anguita M, Torres F, et al. Incidence of specific etiology and role of methods
for specific etiologic diagnosis of primary acute pericarditis. Am J Cardiol 1995; 75:378.
19. Imazio M, Spodick DH, Brucato A, et al. Controversial issues in the management of
pericardial diseases. Circulation 2010; 121:916.
20. Campbell PT, Li JS, Wall TC, et al. Cytomegalovirus pericarditis: a case series and review of
the literature. Am J Med Sci 1995; 309:229.
22. Correale E, Maggioni AP, Romano S, et al. Comparison of frequency, diagnostic and
prognostic significance of pericardial involvement in acute myocardial infarction treated with
and without thrombolytics. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto
Miocardico (GISSI). Am J Cardiol 1993; 71:1377.
23. Belkin RN, Mark DB, Aronson L, et al. Pericardial effusion after intravenous recombinant
tissue-type plasminogen activator for acute myocardial infarction. Am J Cardiol 1991; 67:496.
24. Shahar A, Hod H, Barabash GM, et al. Disappearance of a syndrome: Dressler's syndrome
in the era of thrombolysis. Cardiology 1994; 85:255.
25. Stevenson LW, Child JS, Laks H, Kern L. Incidence and significance of early
pericardial effusions after cardiac surgery. Am J Cardiol 1984; 54:848.
26. Hauptman PJ, Couper GS, Aranki SF, et al. Pericardial effusions after cardiac transplantation.
J Am Coll Cardiol 1994; 23:1625.
27. Quin JA, Tauriainen MP, Huber LM, et al. Predictors of pericardial effusion after orthotopic
heart transplantation. J Thorac Cardiovasc Surg 2002; 124:979.
28. Stewart JR, Fajardo LF, Gillette SM, Constine LS. Radiation injury to the heart. Int J
Radiat Oncol Biol Phys 1995; 31:1205.
29. Applefeld MM, Wiernik PH. Cardiac disease after radiation therapy for Hodgkin's
disease: analysis of 48 patients. Am J Cardiol 1983; 51:1679.
31. Rostand SG, Rutsky EA. Pericarditis in end-stage renal disease. Cardiol Clin 1990; 8:701.
32. Gunukula SR, Spodick DH. Pericardial disease in renal patients. Semin Nephrol 2001; 21:52.
33. Kabadi UM, Kumar SP. Pericardial effusion in primary hypothyroidism. Am Heart J
1990; 120:1393.
34. Sekiguchi H, Horie R, Suri RM, et al. Constrictive pericarditis caused by immunoglobulin
G4-related disease. Circ Heart Fail 2012; 5:e30.
GRAPHICS
Infectious
Viral - Coxsackievirus, echovirus, adenovirus, Epstein-Barr virus, cytomegalovirus, influenza, varicella, rubella, HIV,
hepatitis B, mumps, parvovirus B19, vaccina (smallpox vaccine)
Bacterial - Mycobacterium tuberculosis (most common cause in countries where tuberculosis is endemic),
Staphylococcus, Streptococcus, Haemophilus, Neisseria (N. gonorrhoeae or N. meningitidis), Chlamydia (C. psittaci or
C. trachomatis), Legionella, Salmonella, Borrelia burgdorferi (the cause of Lyme disease), Mycoplasma, Actinomyces,
Nocardia, Tropheryma whippelii, Treponema, Rickettsia
Noninfectious
Systemic inflammatory diseases, especially lupus, rheumatoid arthritis, scleroderma, Sjögren syndrome, vasculitis,
mixed connective disease
Autoinflammatory diseases (especially familial Mediterranean fever and tumor necrosis factor associated periodic
syndrome [TRAPS], IgG4-related disease)
Other - Granulomatosis with polyangiitis (Wegener's), polyarteritis nodosa, sarcoidosis, inflammatory bowel disease
(Crohn's, ulcerative colitis), Whipple's, giant cell arteritis, Behçet syndrome, rheumatic fever
Neoplasm
Paraneoplastic
Cardiac
Late postcardiac injury syndrome (Dressler's syndrome), also seen in other settings (eg, post-myocardial infarction
and post-cardiac surgery)
Myocarditis
Trauma
Blunt
Penetrating
Metabolic
Uremia
Radiation
https://www.uptodate.com/contents/etiology-of-pericardial-disease/print?search=efusi pericard&source=search_result&selectedTitle=18~150&usage… 15/20
4/10/2019 Etiology of pericardial disease - UpToDate
Drugs (rare)
References:
1. LeWinter M. Clinical practice. Acute pericarditis. N Engl J Med 2014; 371:2410.
2. Imazio M, Gaita F. Diagnosis and treatment of pericarditis. Heart 2015; 101:1159.
3. Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol 2012; 27:308.
Data from:
1. Permanyer-Miralda G, Sagrista-Sauleda J, Soler-Soler J. Primary acute pericardial disease: A prospective series of 231
consecutive patients. Am J Cardiol 1985; 56:623.
2. Zayas R, Anguita M, Torres F, et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of
primary acute pericarditis. Am J Cardiol 1995; 75:378.
3. Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation 2007; 115:2739.
4. Reuter H, Burgess LJ, Louw VJ, et al. The management of tuberculous pericardial effusion: experience in 233
consecutive patients. Cardiovasc J S Afr 2007; 18:20.
5. Gouriet F, Levy PY, Casalta JP, et al. Etiology of pericarditis in a prospective cohort of 1162 cases. Am J Med 2015;
128:784.
Corey, Strobbe,
Sagrista-Sauleda, Levy, 2003 Ma, 2012
1993 (N = 2017 (N =
2000 (N = 322) (N = 204) (N = 140)
57) 269)
Etiologies, percent
Malignancy 13 23 15 38 25
Uremia 6 12 2 6 3
Iatrogenic 16 0 0 9 21
Post-acute 8 0 0 5 1
myocardial
infarction
Infection 6 27 16 28 7
Collagen 5 12 10 6 3
vascular
disease
Hypothyroidism 2 0 10 5 0
Other 15 23 0 3 14
Adapted from:
1. Sagrista-Sauleda J, Merce J, Permanyer-Maralda G, et al. Clinical clues to the causes of large pericardial effusions. Am J
Med 2000; 109:95.
2. Corey GR, Campbell PT, VanTrigt P, et al. Etiology of large pericardial effusion. Am J Med 1993; 95:209.
3. Levy PY, Corey R, Berger P, et al. Etiologic diagnosis of 204 pericardial effusion. Medicine (Baltimore) 2003; 82:385.
4. Ma W, Liu J, Zeng Y, et al. Causes of moderate to large pericardial effusion requiring pericardiocentesis in 140 Han
Chinese patients. Herz 2012; 37: 183.
5. Strobbe A, Adriaenssens T, Bennett J, et al. Etiology and long-term outcome of patients undergoing pericardiocentesis.
J Am Heart Assoc 2017; 6: e007598.
Tocainide Cyclophosphamide
Hydralazine Cyclosporine
Methyldopa Mesalazine
Mesalazine 5-Fluorouracil
Isoniazid GM-CSF
Hydantoins Anthracycline derivatives
Penicillins Daunorubicin
Methysergide Venom
Minoxidil Scorpion fish sting
Phenylbutazone Silicones
Streptokinase Asbestos
p-Aminosalicylic acid Secondary pericardial
Thiazides bleeding/hemopericardium
Streptomycin Anticoagulants
Reproduced with permission from: Maisch B, Seferovic PM, Ristic AD, et al. Guidelines on the diagnosis and management of
pericardial diseases executive summary; The Task force on the diagnosis and management of pericaridal diseases of the
European society of cardiology. Eur Heart J 2004; 25:587. Copyright © 2004 European Society of Cardiology.
Contributor Disclosures
Brian D Hoit, MD Speaker's Bureau: Philips Medical [Heart valve disease (3D Transesophageal echo)].
Martin M LeWinter, MD Nothing to disclose Jae K Oh, MD Nothing to disclose Brian C Downey, MD, FACC
Nothing to disclose
Contributor disclosures are reviewed for conflicts of interest by the editorial group. When found, these are
addressed by vetting through a multi-level review process, and through requirements for references to be
provided to support the content. Appropriately referenced content is required of all authors and must conform
to UpToDate standards of evidence.